eight is something that I've thought about every single day of my adult life," says Jennifer Blackburn*, a 49-year-old public relations professional in Toronto. Following decades of trying different diets and medications-and finding little success-in fall 2022 she started taking Ozempic, the diabetes drug that has become synonymous with celebrity weight loss.
"It has been life-changing," she says.
U.S. health-care providers wrote more than 9 million prescriptions for Ozempic and similar drugs during the last few months of 2022, around the time Blackburn received her script.
Some 890 million adults have obesity worldwide, and weight-loss drug sales are forecast to grow to as much as $100 billion by the end of the decade.
No wonder obesity medications are a hot topic. But there's still mass confusion around who should take them, whether the potential side effects are worth it, and whether people who truly need them can access-and affordthe limited supply.
How do the new obesity drugs work?
Ozempic was approved by the FDA in 2017 for the treatment of type 2 diabetes.
Once the manufacturer, Novo Nordisk, tapped into the drug's added benefit of triggering substantial weight loss, it soon had another drug in the works: Wegovy, with a higher dose of the same active ingredient, semaglutide, was approved in 2021 for the treatment of obesity. The company also makes an oral form of semaglutide called Rybelsus for type 2 diabetes.
In addition to semaglutide, there is also tirzepatide, which is prescribed as Mounjaro for diabetes and Zepbound for obesity. (Again, the active ingredient is the same, but the drugs are prescribed under different names with slightly different doses.) Another diabetes drug, liraglutide, is marketed as Saxenda for weight loss. And dulaglutide is sold as Trulicity for diabetes management.
Diese Geschichte stammt aus der June 2024-Ausgabe von Reader's Digest US.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der June 2024-Ausgabe von Reader's Digest US.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Election Day Memories - Stories about voting by the people, for the people
A Convincing Argument When my boyfriend and I were finally old enough to vote in our first presidential election, we spent months debating with one another about our chosen candidates. We were quite persuasive, as we discovered when we got home from the polls and learned that we'd both voted for the other's initial choice.―SHERRY FOX Appleton, WI
A New Way to Monitor Blood Sugar
Who can benefit from this wearable technology
A Flag for Dad
An old sailor made a last wish. His son was determined to see that it came true.
Sisterhood to Last a Lifetime
These college pals teach a master class in how to maintain a friendship for 50-plus years
...TO DIE ON A HOCKEY RINK
ONE MINUTE I WAS PLAYING IN MY BEER LEAGUE, THE NEXT I WAS IN THE HOSPITAL
Yes, There's a Museum for That!
These collections are wacky, wonderful and worth a visit
Town Meeting Is Called!
Once a year, the people of Elmore, Vermont, gather to practice a cherished right: democracy
Just Tight
Broken, battered and trapped in a ravine for days, a desperate driver wonders, \"Will anyone find me?\"
WHY OUR BODIES DON'T DIG DAYLIGHT SAVING TIME
Twice a year, when we spring ahead and fall back, we're more prone to sleepiness, depression and accidents
MONEYSAVING DO'S AND DON'TS
The run-up to the holidays doesn't have to bah-humbug your budget. A shopping expert shares strategies for saving big now and all year round.
